US Stock MarketDetailed Quotes

BioXcel Therapeutics (BTAI)

Watchlist

1.110
+0.020+1.83%

Close Jun 11 16:00 ET

1.150
+0.040+3.60%

Pre 07:21 ET

34.27MMarket Cap-0.23P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioXcel Therapeutics (BTAI) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Total revenue

22.62%206K

-71.67%642K

-30.05%256K

-54.21%98K

-89.13%120K

-71.13%168K

64.20%2.27M

-2.66%366K

-37.24%214K

141.58%1.1M

Operating revenue

22.62%206K

-71.67%642K

-30.05%256K

-54.21%98K

-89.13%120K

-71.13%168K

64.20%2.27M

-2.66%366K

-37.24%214K

141.58%1.1M

Cost of revenue

1,921.43%283K

-92.35%164K

-96.15%32K

-99.06%11K

72.58%107K

-82.50%14K

70.08%2.14M

16.53%832K

128.52%1.17M

138.46%62K

Gross profit

-150.00%-77K

288.62%478K

148.07%224K

109.10%87K

-98.75%13K

-69.32%154K

2.50%123K

-37.87%-466K

-459.06%-956K

141.76%1.04M

Operating expense

-1.04%10.15M

-21.84%50.75M

5.11%10.51M

10.46%14.12M

-9.25%15.87M

-58.43%10.25M

-61.29%64.93M

-48.84%10M

-70.92%12.78M

-66.92%17.48M

Selling and administrative expenses

26.18%7.19M

-40.58%20.49M

-7.06%3.81M

-29.96%5.38M

-40.65%5.61M

-57.03%5.7M

-58.65%34.49M

-57.37%4.09M

-68.44%7.68M

-63.47%9.45M

-Selling and marketing expense

----

-70.70%407K

-82.37%85K

-58.78%115K

105.29%38K

----

-88.87%1.39M

51.10%482K

-90.67%279K

-114.94%-718K

-General and administrative expense

26.18%7.19M

-39.32%20.09M

2.99%3.72M

-28.88%5.27M

-45.21%5.57M

-57.03%5.7M

-53.33%33.1M

-61.09%3.61M

-65.33%7.4M

-51.73%10.17M

Research and development costs

-35.11%2.96M

-0.60%30.25M

13.56%6.7M

71.34%8.74M

27.69%10.26M

-60.06%4.55M

-63.91%30.44M

-40.60%5.9M

-74.00%5.1M

-70.22%8.03M

Operating profit

-1.23%-10.22M

22.43%-50.27M

1.71%-10.28M

-2.14%-14.03M

3.58%-15.85M

58.20%-10.1M

61.34%-64.8M

47.37%-10.46M

68.87%-13.74M

68.63%-16.44M

Net non-operating interest income expense

-7.35%-3.99M

-27.07%-15.92M

-11.22%-4.08M

-30.34%-4.14M

-31.79%-3.99M

-39.62%-3.71M

-63.43%-12.53M

-47.21%-3.66M

-45.33%-3.17M

-84.92%-3.03M

Non-operating interest income

-24.37%211K

-59.03%1.07M

-12.77%321K

-61.69%236K

-65.72%230K

-70.54%279K

-53.94%2.6M

-61.10%368K

-42.32%616K

-58.61%671K

Non-operating interest expense

5.13%4.2M

12.26%16.98M

9.03%4.4M

15.38%4.37M

14.11%4.22M

10.70%3.99M

13.63%15.13M

17.38%4.03M

16.54%3.79M

13.53%3.7M

Other net income (expense)

-76.84%1.52M

-120.93%-3.71M

-44.52%1.81M

-490.32%-12.74M

-94.12%657K

20,396.88%6.56M

570.47%17.73M

2,924.07%3.27M

178.31%3.26M

1,980.07%11.17M

Special income (charges)

----

92.05%-194K

--0

87.51%-194K

--0

----

41.36%-2.44M

---32K

62.70%-1.55M

---856K

-Less：Restructuring and merger&acquisition

----

-92.05%194K

--0

-87.51%194K

--0

----

-41.36%2.44M

--32K

-62.70%1.55M

--856K

Other non- operating income (expenses)

-76.84%1.52M

-117.44%-3.52M

-45.06%1.81M

-360.45%-12.55M

-94.54%657K

20,396.88%6.56M

5,020.05%20.17M

2,953.70%3.3M

96,440.00%4.82M

2,139.48%12.03M

Income before tax

-74.95%-12.69M

-17.28%-69.9M

-15.53%-12.55M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

66.71%-59.6M

51.21%-10.86M

72.96%-13.65M

84.49%-8.3M

Income tax

Net income

-74.95%-12.69M

-17.28%-69.9M

-15.53%-12.55M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

66.71%-59.6M

51.21%-10.86M

72.96%-13.65M

84.49%-8.3M

Net income continuous Operations

-74.95%-12.69M

-17.28%-69.9M

-15.53%-12.55M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

66.71%-59.6M

51.21%-10.86M

72.96%-13.65M

84.49%-8.3M

Minority interest income

Net income attributable to the parent company

-74.95%-12.69M

-17.28%-69.9M

-15.53%-12.55M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

66.71%-59.6M

51.21%-10.86M

72.96%-13.65M

84.49%-8.3M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-74.95%-12.69M

-17.28%-69.9M

-15.53%-12.55M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

66.71%-59.6M

51.21%-10.86M

72.96%-13.65M

84.49%-8.3M

Basic earnings per share

64.00%-0.54

75.63%-5.73

84.26%-0.5619

57.67%-2.18

25.76%-2.45

89.20%-1.5

76.09%-23.51

70.64%-3.57

81.29%-5.15

88.73%-3.3

Diluted earnings per share

64.00%-0.54

75.63%-5.73

84.26%-0.5619

57.67%-2.18

25.76%-2.45

89.20%-1.5

76.09%-23.51

70.64%-3.57

81.29%-5.15

88.73%-3.3

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Total revenue	22.62%206K	-71.67%642K	-30.05%256K	-54.21%98K	-89.13%120K	-71.13%168K	64.20%2.27M	-2.66%366K	-37.24%214K	141.58%1.1M
Operating revenue	22.62%206K	-71.67%642K	-30.05%256K	-54.21%98K	-89.13%120K	-71.13%168K	64.20%2.27M	-2.66%366K	-37.24%214K	141.58%1.1M
Cost of revenue	1,921.43%283K	-92.35%164K	-96.15%32K	-99.06%11K	72.58%107K	-82.50%14K	70.08%2.14M	16.53%832K	128.52%1.17M	138.46%62K
Gross profit	-150.00%-77K	288.62%478K	148.07%224K	109.10%87K	-98.75%13K	-69.32%154K	2.50%123K	-37.87%-466K	-459.06%-956K	141.76%1.04M
Operating expense	-1.04%10.15M	-21.84%50.75M	5.11%10.51M	10.46%14.12M	-9.25%15.87M	-58.43%10.25M	-61.29%64.93M	-48.84%10M	-70.92%12.78M	-66.92%17.48M
Selling and administrative expenses	26.18%7.19M	-40.58%20.49M	-7.06%3.81M	-29.96%5.38M	-40.65%5.61M	-57.03%5.7M	-58.65%34.49M	-57.37%4.09M	-68.44%7.68M	-63.47%9.45M
-Selling and marketing expense	----	-70.70%407K	-82.37%85K	-58.78%115K	105.29%38K	----	-88.87%1.39M	51.10%482K	-90.67%279K	-114.94%-718K
-General and administrative expense	26.18%7.19M	-39.32%20.09M	2.99%3.72M	-28.88%5.27M	-45.21%5.57M	-57.03%5.7M	-53.33%33.1M	-61.09%3.61M	-65.33%7.4M	-51.73%10.17M
Research and development costs	-35.11%2.96M	-0.60%30.25M	13.56%6.7M	71.34%8.74M	27.69%10.26M	-60.06%4.55M	-63.91%30.44M	-40.60%5.9M	-74.00%5.1M	-70.22%8.03M
Operating profit	-1.23%-10.22M	22.43%-50.27M	1.71%-10.28M	-2.14%-14.03M	3.58%-15.85M	58.20%-10.1M	61.34%-64.8M	47.37%-10.46M	68.87%-13.74M	68.63%-16.44M
Net non-operating interest income expense	-7.35%-3.99M	-27.07%-15.92M	-11.22%-4.08M	-30.34%-4.14M	-31.79%-3.99M	-39.62%-3.71M	-63.43%-12.53M	-47.21%-3.66M	-45.33%-3.17M	-84.92%-3.03M
Non-operating interest income	-24.37%211K	-59.03%1.07M	-12.77%321K	-61.69%236K	-65.72%230K	-70.54%279K	-53.94%2.6M	-61.10%368K	-42.32%616K	-58.61%671K
Non-operating interest expense	5.13%4.2M	12.26%16.98M	9.03%4.4M	15.38%4.37M	14.11%4.22M	10.70%3.99M	13.63%15.13M	17.38%4.03M	16.54%3.79M	13.53%3.7M
Other net income (expense)	-76.84%1.52M	-120.93%-3.71M	-44.52%1.81M	-490.32%-12.74M	-94.12%657K	20,396.88%6.56M	570.47%17.73M	2,924.07%3.27M	178.31%3.26M	1,980.07%11.17M
Special income (charges)	----	92.05%-194K	--0	87.51%-194K	--0	----	41.36%-2.44M	---32K	62.70%-1.55M	---856K
-Less：Restructuring and merger&acquisition	----	-92.05%194K	--0	-87.51%194K	--0	----	-41.36%2.44M	--32K	-62.70%1.55M	--856K
Other non- operating income (expenses)	-76.84%1.52M	-117.44%-3.52M	-45.06%1.81M	-360.45%-12.55M	-94.54%657K	20,396.88%6.56M	5,020.05%20.17M	2,953.70%3.3M	96,440.00%4.82M	2,139.48%12.03M
Income before tax	-74.95%-12.69M	-17.28%-69.9M	-15.53%-12.55M	-126.45%-30.91M	-131.20%-19.19M	72.92%-7.25M	66.71%-59.6M	51.21%-10.86M	72.96%-13.65M	84.49%-8.3M
Income tax
Net income	-74.95%-12.69M	-17.28%-69.9M	-15.53%-12.55M	-126.45%-30.91M	-131.20%-19.19M	72.92%-7.25M	66.71%-59.6M	51.21%-10.86M	72.96%-13.65M	84.49%-8.3M
Net income continuous Operations	-74.95%-12.69M	-17.28%-69.9M	-15.53%-12.55M	-126.45%-30.91M	-131.20%-19.19M	72.92%-7.25M	66.71%-59.6M	51.21%-10.86M	72.96%-13.65M	84.49%-8.3M
Minority interest income
Net income attributable to the parent company	-74.95%-12.69M	-17.28%-69.9M	-15.53%-12.55M	-126.45%-30.91M	-131.20%-19.19M	72.92%-7.25M	66.71%-59.6M	51.21%-10.86M	72.96%-13.65M	84.49%-8.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-74.95%-12.69M	-17.28%-69.9M	-15.53%-12.55M	-126.45%-30.91M	-131.20%-19.19M	72.92%-7.25M	66.71%-59.6M	51.21%-10.86M	72.96%-13.65M	84.49%-8.3M
Basic earnings per share	64.00%-0.54	75.63%-5.73	84.26%-0.5619	57.67%-2.18	25.76%-2.45	89.20%-1.5	76.09%-23.51	70.64%-3.57	81.29%-5.15	88.73%-3.3
Diluted earnings per share	64.00%-0.54	75.63%-5.73	84.26%-0.5619	57.67%-2.18	25.76%-2.45	89.20%-1.5	76.09%-23.51	70.64%-3.57	81.29%-5.15	88.73%-3.3
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm